Search results for " Ring"

showing 10 items of 478 documents

Eight-Membered Rings With Two Heteroatoms 1,2

2022

The chapter titled “Eight-membered Rings with two Heteroatoms 1,2” deals with heterocine rings with two heteroatoms in a 1,2 relationship, namely 1,2-diazocine, 2H-1,2-oxazocine, 2H-1,2-thiazocine, 1,2-dioxocin, 1,2-oxathiocin and 1,2-dithiocin. This article covers the literature from 2007 to 2019 and reports the chemistry of uncondensed derivatives, heterocines fused to carbocycles and heterocycles, as well as bridged heterocines. As usual, in the case that a particular section is not mentioned, it means that no chemistry has been reported. In this article, the “Biosynthesis” paragraph was additionally introduced, since in the latest years the contribution of Nature to the synthesis of dih…

12-DiazocineAntihuman African Trypanosomiasis12-Oxathiocin12-DithiocinAnticancer agentsPhotoisomerizationRing-opening metathesis polymerization2H-12-ThiazocineDiene ring-closing metathesisSettore CHIM/08 - Chimica Farmaceutica12-Dioxocin2H-12-OxazocineAntimalarial agents
researchProduct

Lie Algebras Generated by Extremal Elements

1999

We study Lie algebras generated by extremal elements (i.e., elements spanning inner ideals of L) over a field of characteristic distinct from 2. We prove that any Lie algebra generated by a finite number of extremal elements is finite dimensional. The minimal number of extremal generators for the Lie algebras of type An, Bn (n>2), Cn (n>1), Dn (n>3), En (n=6,7,8), F4 and G2 are shown to be n+1, n+1, 2n, n, 5, 5, and 4 in the respective cases. These results are related to group theoretic ones for the corresponding Chevalley groups.

17B05[ MATH.MATH-GR ] Mathematics [math]/Group Theory [math.GR]Non-associative algebraAdjoint representationGroup Theory (math.GR)01 natural sciences[MATH.MATH-GR]Mathematics [math]/Group Theory [math.GR]Graded Lie algebraCombinatoricsMathematics - Algebraic Geometry0103 physical sciences[MATH.MATH-RA] Mathematics [math]/Rings and Algebras [math.RA]FOS: Mathematics0101 mathematicsAlgebraic Geometry (math.AG)[MATH.MATH-GR] Mathematics [math]/Group Theory [math.GR]MathematicsDiscrete mathematicsAlgebra and Number TheorySimple Lie group010102 general mathematics[MATH.MATH-RA]Mathematics [math]/Rings and Algebras [math.RA]20D06[MATH.MATH-AG] Mathematics [math]/Algebraic Geometry [math.AG]Mathematics - Rings and AlgebrasKilling formAffine Lie algebra[ MATH.MATH-RA ] Mathematics [math]/Rings and Algebras [math.RA]Lie conformal algebra[ MATH.MATH-AG ] Mathematics [math]/Algebraic Geometry [math.AG]Adjoint representation of a Lie algebraRings and Algebras (math.RA)17B05; 20D06010307 mathematical physics[MATH.MATH-AG]Mathematics [math]/Algebraic Geometry [math.AG]Mathematics - Group TheoryJournal of Algebra
researchProduct

Direct measurement of resonance driving terms in the super proton synchrotron (SPS) of cern using beam position monitors

2003

El objetivo principal de esta tesis consiste en desarrollar un metodo para medir los terminos resonantes del Hamiltoniano de un acelerador mediante la transfomada de Fourier de la posicion del haz vuelta tras vuelta. Dos aspectos fundamentales de este metodo de medida son: el efecto de la decoherencia del haz en el espectro de Fourier y la variacion longitudinal de estos terminos resonantes. Ambos se estudian analiticamente y mediante simulaciones numericas. Con el fin de probar la validez de esta tecnica se realizaron experimentos en dos aceleradores de hadrones: el SPS del CERN y el RHIC del BNL. Por ultimo se estudia como utilizar dipolos AC para que esta tecnica no sea destructiva

53nonePhysics::Accelerator PhysicsFísicaNuclear ExperimentAccelerators and Storage Rings
researchProduct

Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations

2007

Policy Forum. Competing interests: ER has received research grants from Daiichi, Bayer, and Theravance and has served as a consultant to Pfizer, Theravance, Bayer, Wyeth, Rosetta, and BiondVax. Summary Points Brucellosis remains the commonest anthropozoonosis worldwide, and its treatment remains complex, requiring protracted administration of more than one antibiotic. In November 2006, a consensus meeting aimed at reaching a common specialist statement on the treatment of brucellosis was held in Ioannina, Greece under the auspices of the International Society of Chemotherapy and the Institute of Continuing Medical Education of Ioannina. The author panel suggests that the optimal treatment o…

:Diseases::Pathological Conditions Signs and Symptoms::Pathologic Processes::Disease Attributes::Recurrence [Medical Subject Headings]Veterinary medicine:Chemicals and Drugs::Carbohydrates::Glycosides::Aminoglycosides::Streptomycin [Medical Subject Headings]:Phenomena and Processes::Microbiological Phenomena::Drug Resistance Microbial [Medical Subject Headings]DiseaseGlobal Health:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]:Health Care::Population Characteristics::Health::World Health [Medical Subject Headings]Terminología como AsuntoBrucellosi:Organisms::Eukaryota::Animals [Medical Subject Headings]:Health Care::Health Care Economics and Organizations::Organizations::International Agencies::United Nations::World Health Organization [Medical Subject Headings]Policy ForumMedicine in Developing CountriesGentamicinasDrug Resistance MicrobialBrucelosisAdhesión a DirectrizGeneral MedicineHumanosDrug CombinationsAntibacterianosDoxycyclineStreptomycinEstreptomicinaMedicine:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds with 4 or More Rings::Rifamycins::Rifampin [Medical Subject Headings]Drug Therapy CombinationGuideline AdherenceRifampinFluoroquinolonesSalud Mundialmedicine.medical_specialtyEfficacyResultado del TratamientoInvestigación BiomédicaRecurrenciaTherapeuticsWorld Health OrganizationMicrobiologyAntibiotic resistanceTerminology as Topic:Disciplines and Occupations::Social Sciences::Internationality::International Cooperation::Developing Countries [Medical Subject Headings]HumansMedical journalIntensive care medicineDeveloping Countries:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 1-Ring::Pyrimidines::Trimethoprim::Trimethoprim-Sulfamethoxazole Combination [Medical Subject Headings]medicine.diseaseCotrimoxazoleAnimalesQuimioterapia:Humanities::Humanities::History::History Modern 1601-::History 21st Century [Medical Subject Headings]GentamicinsBrucel·losiBiomedical ResearchCommunicable diseases:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 2-Ring::Quinolines::Quinolones::Fluoroquinolones [Medical Subject Headings]Human diseaseRecurrence:Chemicals and Drugs::Pharmaceutical Preparations::Drug Combinations [Medical Subject Headings]:Information Science::Information Science::Communication::Language::Linguistics::Terminology as Topic [Medical Subject Headings]biologyIraqi patientsRMetaanalysis:Diseases::Bacterial Infections and Mycoses::Bacterial Infections::Gram-Negative Bacterial Infections::Brucellosis [Medical Subject Headings]Historia del Siglo XXIAnti-Bacterial AgentsCombinación Trimetoprim-SulfametoxazolTreatment OutcomeInfectious Diseases:Disciplines and Occupations::Natural Science Disciplines::Science::Research::Biomedical Research [Medical Subject Headings]:Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons Cyclic::Hydrocarbons Aromatic::Polycyclic Hydrocarbons Aromatic::Naphthacenes::Tetracyclines::Doxycycline [Medical Subject Headings]Fluoroquinolonas:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents [Medical Subject Headings]:Chemicals and Drugs::Carbohydrates::Glycosides::Aminoglycosides::Gentamicins [Medical Subject Headings]Países en Desarrollo:Analytical Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Therapy Combination [Medical Subject Headings]BrucellaHistory 21st CenturyBrucellosisWorld healthTrimethoprim Sulfamethoxazole Drug CombinationmedicineAnimals:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome [Medical Subject Headings]Resistencia a Medicamentosbusiness.industryOrganización Mundial de la SaludBrucellosisMalalties infecciosesTerapèuticabiology.organism_classificationCombinación de MedicamentosDoxiciclinaTherapybusinessBrucella melitensisPLoS Medicine
researchProduct

Present status and first results of the final focus beam line at the KEK Accelerator Test Facility

2011

ATF2 is a final-focus test beam line which aims to focus the low emittance beam from the ATF damping ring to a vertical size of about 37 nm and to demonstrate nanometer level beam stability. Several advanced beam diagnostics and feedback tools are used. In December 2008, construction and installation were completed and beam commissioning started, supported by an international team of Asian, European, and U.S. scientists. The present status and first results are described.

Accelerator Physics (physics.acc-ph)Nuclear and High Energy PhysicsLow emittancePhysics and Astronomy (miscellaneous)Nuclear engineering[PHYS.PHYS.PHYS-ACC-PH]Physics [physics]/Physics [physics]/Accelerator Physics [physics.acc-ph]FOS: Physical sciencesbeam transport01 natural sciencesBeam characteristicslaw.inventionNuclear physicslaw0103 physical sciencesddc:530lcsh:Nuclear and particle physics. Atomic energy. RadioactivityBeam handling010306 general physicsAccelerator Test FacilityPhysicsFocus (computing)Research Groups and Centres\Physics\Low Temperature Physics010308 nuclear & particles physicsFaculty of Science\PhysicsBeam commissioningFísicaParticle acceleratorSurfaces and Interfaces29.27.Eg 29.27.Fh 29.20.dbAccelerators and Storage RingsStorage rings and collidersCOLLIDERSTechnology for normal conducting higher energy linear accelerators [9]BeamlineTest beamlcsh:QC770-798Physics - Accelerator PhysicsBeam (structure)
researchProduct

New exotic beams from the SPIRAL 1 upgrade

2018

Since 2001, the SPIRAL 1 facility has been one of the pioneering facilities in ISOL techniques for reaccelerating radioactive ion beams: the fragmentation of the heavy ion beams of GANIL on graphite targets and subsequent ionization in the Nanogan ECR ion source has permitted to deliver beams of gaseous elements (He, N, O, F, Ne, Ar, Kr) to numerous experiments. Thanks to the CIME cyclotron, energies up to 20 AMeV could be obtained. In 2014, the facility was stopped to undertake a major upgrade, with the aim to extend the production capabilities of SPIRAL 1 to a number of new elements. This upgrade, which is presently under commissioning, consists in the integration of an ECR booster in the…

Accelerator Physics (physics.acc-ph)Nuclear and High Energy PhysicsNuclear engineering[PHYS.PHYS.PHYS-ACC-PH]Physics [physics]/Physics [physics]/Accelerator Physics [physics.acc-ph]tutkimuslaitteetCyclotronFOS: Physical scienceshiukkaskiihdyttimet[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]nucl-ex7. Clean energy01 natural sciencesIonlaw.inventionion sourceslawIonization0103 physical sciencesIon sourcesNuclear Physics - ExperimentNuclear Experiment (nucl-ex)radioactive ion beams010306 general physicsNuclear ExperimentInstrumentationRadioactive ion beamsphysics.acc-ph[PHYS]Physics [physics]Physics010308 nuclear & particles physicsAccelerators and Storage RingsIon sourceUpgradesäteilyfysiikkaBeamlinePhysics - Accelerator PhysicsAGATABeam (structure)
researchProduct

Polarization-Dependent Disappearance of a Resonance Signal -- Indication for Optical Pumping in a Storage Ring?

2021

We report on laser spectroscopic measurements on Li$^+$ ions in the experimental storage ring ESR at the GSI Helmholtz Centre for Heavy Ion Research. Driving the $2s\,^3\!{S}_1\;(F=\frac{3}{2}) \,\leftrightarrow\,2p\,^3\!P_2\;(F=\frac{5}{2}) \leftrightarrow 2s\,^3\!{S}_1\;(F=\frac{5}{2})$ $\Lambda$-transition in $^7$Li$^+$ with two superimposed laser beams it was found that the use of circularly polarized light leads to a disappearance of the resonance structure in the fluorescence signal. This can be explained by optical pumping into a dark state of polarized ions. We present a detailed theoretical analysis of this process that supports the interpretation of optical pumping and demonstrate…

Accelerator Physics (physics.acc-ph)Nuclear and High Energy PhysicsPhysics and Astronomy (miscellaneous)Atomic Physics (physics.atom-ph)FOS: Physical sciences53001 natural sciencesIonlaw.inventionPhysics - Atomic PhysicsOptical pumpinglaw0103 physical scienceslcsh:Nuclear and particle physics. Atomic energy. Radioactivityddc:530010306 general physicsCircular polarizationPhysics010308 nuclear & particles physicsSurfaces and InterfacesLaserPolarization (waves)FluorescenceDark statelcsh:QC770-798Physics - Accelerator PhysicsAtomic physicsStorage ring
researchProduct

Simulations and measurements of beam loss patterns at the CERN Large Hadron Collider

2014

The CERN Large Hadron Collider (LHC) is designed to collide proton beams of unprecedented energy, in order to extend the frontiers of high-energy particle physics. During the first very successful running period in 2010-2013, the LHC was routinely storing protons at 3.5-4 TeV with a total beam energy of up to 146 MJ, and even higher stored energies are foreseen in the future. This puts extraordinary demands on the control of beam losses. An uncontrolled loss of even a tiny fraction of the beam could cause a superconducting magnet to undergo a transition into a normal-conducting state, or in the worst case cause material damage. Hence a multistage collimation system has been installed in ord…

Accelerator Physics (physics.acc-ph)Nuclear and High Energy PhysicsPhysics and Astronomy (miscellaneous)Monte Carlo methodFOS: Physical sciencesSuperconducting magnetTracking (particle physics)law.inventionNuclear physicslawlcsh:Nuclear and particle physics. Atomic energy. RadioactivityNuclear Experiment (nucl-ex)Large Hadron Collider (France and Switzerland)Nuclear ExperimentPhysicsLarge Hadron ColliderColliders (Nuclear physics)Particle acceleratorCollimatorSurfaces and InterfacesAccelerators and Storage RingsOrders of magnitude (time)lcsh:QC770-798Physics::Accelerator PhysicsPhysics - Accelerator PhysicsBeam (structure)
researchProduct

UFOs in the LHC: Observations, studies and extrapolations

2012

Unidentified falling objects (UFOs) are potentially a major luminosity limitation for nominal LHC operation. They are presumably micrometer sized dust particles which lead to fast beam losses when they interact with the beam. With large-scale increases and optimizations of the beam loss monitor (BLM) thresholds, their impact on LHC availability was mitigated from mid 2011 onwards. For higher beam energy and lower magnet quench limits, the problem is expected to be considerably worse, though. In 2011/12, the diagnostics for UFO events were significantly improved: dedicated experiments and measurements in the LHC and in the laboratory were made and complemented by FLUKA simulations and theore…

Accelerators and Storage Rings
researchProduct

Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy

2018

Purpose This multicenter phase II trial evaluated lurbinectedin (PM01183), a selective inhibitor of active transcription of protein-coding genes, in patients with metastatic breast cancer. A unicenter translational substudy assessed potential mechanisms of lurbinectedin resistance. Patients and Methods Two arms were evaluated according to germline BRCA1/2 status: BRCA1/2 mutated (arm A; n = 54) and unselected ( BRCA1/2 wild-type or unknown status; arm B; n = 35). Lurbinectedin starting dose was a 7-mg flat dose and later, 3.5 mg/m2 in arm A. The primary end point was objective response rate (ORR) per Response Evaluation Criteria in Solid Tumors (RECIST). The translational substudy of resist…

Adult0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyGenes BRCA2Genes BRCA1Phases of clinical researchAntineoplastic AgentsBreast NeoplasmsHeterocyclic Compounds 4 or More RingsMice03 medical and health sciences0302 clinical medicineGermline mutationInternal medicineBiomarkers TumorClinical endpointAnimalsHumansMedicineProgression-free survivalGerm-Line MutationAgedDose-Response Relationship DrugErratabusiness.industryMiddle Agedmedicine.diseaseXenograft Model Antitumor AssaysMetastatic breast cancerProgression-Free SurvivalClinical trial030104 developmental biologyOncologyResponse Evaluation Criteria in Solid Tumors030220 oncology & carcinogenesisBiomarker (medicine)FemalebusinessCarbolinesJournal of Clinical Oncology
researchProduct